B Vitamin and/or n-3 Fatty Acid Supplementation and Health-Related Quality of Life: Ancillary Findings from the SU.FOL.OM3 Randomized Trial

Valentina A. Andreeva; Clotilde Latarche; Serge Hercberg; Serge Briançon; Pilar Galán; Emmanuelle Kesse‐Guyot

doi:10.1371/journal.pone.0084844

Back

B Vitamin and/or n-3 Fatty Acid Supplementation and Health-Related Quality of Life: Ancillary Findings from the SU.FOL.OM3 Randomized Trial

Article 2014 en

Abstract

1 min read

There were no beneficial effects of supplementation with relatively low doses of B vitamins or n-3 fatty acids on health-related quality of life in cardiovascular disease survivors. The adverse effects of B vitamins on activity limitations and of n-3 fatty acids on vitality among individuals with prior myocardial infarction merit confirmation.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2011

Effect of B-vitamins and <i>n</i>-3 PUFA supplementation for 5 years on blood pressure in patients with CVD

Fabien Szabo de Edelenyi, Anne‐Claire Vergnaud, Namanjeet Ahluwalia, Chantal Julia, Serge Hercberg, Jacques Blacher, Pilar Galán

Article2011

Long-term antioxidant supplementation has no effect on health-related quality of life: The randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial

S. Briançon, Stéphanie Boini, Sandrine Bertrais, F. Guillemin, Pilar Galán, Serge Hercberg

Article2001

The role of N-3 polyunsaturated fatty acids in the prevention andtreatment of cardiovascular disease

Frank B Hu

Article2007

Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial

Roberto Marchioli, Rosa Maria Marfisi, Giovanna Borrelli, Carmelo Chieffo, Maria Grazia Franzosi, Giacomo Levantesi, Aldo Maggioni, Gian Luigi Nicolosi, Marco Scarano, Maria Giuseppina Silletta, Carlo Schweiger, Luigi Tavazzi, Gianni Tognoni

Article2013

Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction

Aldo Maggioni, Gianna Fabbri, Jackie Bosch, Leanne Dyal, Lars Rydén, Hertzel C. Gerstein, Salim Yusuf